Status:
COMPLETED
Construction and External Validation of a Predictive Clinico-biological Score of the Risk of Venous Thrombosis in Women Under Combined Oral Contraceptives
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Venous Thromboembolism
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
the investigators hypothesize that some of these polymorphisms contribute to VTE risk in women using COC, and that their screening could to help assess individual risk of VTE before COC prescription. ...
Eligibility Criteria
Inclusion
- Women who had an episode of documented VTE (deep vein thrombosis and / or pulmonary embolism) under COC who consulted in a specialized counseling center.
- Women of age.
- Subject agreeing to participate in this research, having signed informed consent.
Exclusion
- Absence of COC,
- No knowledge of the COC generation used by the patient,
- Undocumented MTEV Episode
- Absence of available sample (DNA),
- Refusal to participate in the study
Key Trial Info
Start Date :
January 18 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 9 2023
Estimated Enrollment :
1454 Patients enrolled
Trial Details
Trial ID
NCT03309293
Start Date
January 18 2017
End Date
November 9 2023
Last Update
June 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hopitaux de Marseille
Marseille, France, 13354